National Health Investors (NHI)
NYSE:NHI
US Market
Advertisement

National Health Investors (NHI) Ratios

Compare
710 Followers

National Health Investors Ratios

NHI's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, NHI's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
39.68 2.37 5.43 7.20 4.99
Quick Ratio
39.68 2.37 5.43 7.20 0.03
Cash Ratio
20.30 0.15 0.28 0.53 0.49
Solvency Ratio
0.17 0.17 0.13 0.17 0.15
Operating Cash Flow Ratio
56.32 1.24 2.65 3.00 2.65
Short-Term Operating Cash Flow Coverage
0.00 2.45 0.45 0.00 0.51
Net Current Asset Value
$ -1.03B$ -862.10M$ -837.70M$ -816.65M$ -1.16B
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.46 0.46 0.44 0.48
Debt-to-Equity Ratio
0.00 0.91 0.90 0.83 1.00
Debt-to-Capital Ratio
0.00 0.48 0.47 0.45 0.50
Long-Term Debt-to-Capital Ratio
0.00 0.46 0.37 0.45 0.41
Financial Leverage Ratio
1.82 1.98 1.97 1.88 2.06
Debt Service Coverage Ratio
7.60 1.99 0.24 3.21 0.50
Interest Coverage Ratio
5.05 3.22 1.81 2.60 4.18
Debt to Market Cap
0.00 0.47 0.49 0.48 0.48
Interest Debt Per Share
0.59 27.44 26.63 28.49 34.96
Net Debt to EBITDA
-0.38 4.28 7.42 5.70 4.83
Profitability Margins
Gross Profit Margin
63.64%96.40%96.48%96.10%97.10%
EBIT Margin
43.51%59.40%38.77%53.61%70.56%
EBITDA Margin
59.92%81.27%54.64%71.30%91.33%
Operating Profit Margin
39.81%55.90%29.16%44.25%66.34%
Pretax Profit Margin
41.00%42.02%23.55%37.48%55.68%
Net Profit Margin
41.32%42.41%8.29%20.82%40.67%
Continuous Operations Profit Margin
31.80%42.02%23.55%37.48%55.68%
Net Income Per EBT
100.78%100.95%35.21%55.54%73.05%
EBT Per EBIT
102.97%75.16%80.75%84.70%83.93%
Return on Assets (ROA)
5.47%5.45%0.92%2.19%4.34%
Return on Equity (ROE)
10.23%10.82%1.82%4.13%8.95%
Return on Capital Employed (ROCE)
5.28%7.64%3.33%4.77%7.28%
Return on Invested Capital (ROIC)
91.24%7.47%1.00%2.65%4.62%
Return on Tangible Assets
5.47%5.45%0.46%1.10%2.17%
Earnings Yield
4.05%5.60%0.99%2.37%4.38%
Efficiency Ratios
Receivables Turnover
4.57 0.97 3.40 3.00 3.39
Payables Turnover
0.00 0.34 0.39 0.64 0.54
Inventory Turnover
0.00 0.00 0.00 11.64M 0.02
Fixed Asset Turnover
0.00 0.00 0.13 0.13 0.12
Asset Turnover
0.13 0.13 0.11 0.11 0.11
Working Capital Turnover Ratio
2.75 1.25 0.75 0.76 0.92
Cash Conversion Cycle
79.81 -710.97 -833.14 -448.74 15.85K
Days of Sales Outstanding
79.81 376.58 107.40 121.47 107.80
Days of Inventory Outstanding
0.00 0.00 0.00 <0.01 16.43K
Days of Payables Outstanding
0.00 1.09K 940.54 570.21 682.13
Operating Cycle
79.81 376.58 107.40 121.47 16.54K
Cash Flow Ratios
Operating Cash Flow Per Share
4.77 4.25 4.14 4.61 5.19
Free Cash Flow Per Share
4.76 4.16 4.04 4.61 4.88
CapEx Per Share
0.01 0.09 0.10 <0.01 0.31
Free Cash Flow to Operating Cash Flow
1.00 0.98 0.98 1.00 0.94
Dividend Paid and CapEx Coverage Ratio
1.37 1.15 1.11 1.15 1.11
Capital Expenditure Coverage Ratio
437.07 49.28 40.04 3.29K 16.76
Operating Cash Flow Coverage Ratio
0.00 0.16 0.16 0.17 0.15
Operating Cash Flow to Sales Ratio
0.64 0.58 0.67 0.71 0.70
Free Cash Flow Yield
6.18%7.46%7.73%8.02%7.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
24.65 17.86 101.39 42.25 22.84
Price-to-Sales (P/S) Ratio
10.23 7.58 8.40 8.79 9.29
Price-to-Book (P/B) Ratio
2.45 1.93 1.84 1.74 2.04
Price-to-Free Cash Flow (P/FCF) Ratio
16.13 13.41 12.94 12.46 14.16
Price-to-Operating Cash Flow Ratio
16.03 13.14 12.62 12.46 13.32
Price-to-Earnings Growth (PEG) Ratio
25.96 0.04 -1.64 -0.77 0.87
Price-to-Fair Value
2.45 1.93 1.84 1.74 2.04
Enterprise Value Multiple
16.69 13.60 22.81 18.04 15.00
Enterprise Value
3.57B 3.54B 3.47B 3.84B 4.56B
EV to EBITDA
16.73 13.60 22.81 18.04 15.00
EV to Sales
10.03 11.06 12.46 12.86 13.70
EV to Free Cash Flow
15.82 19.57 19.18 18.22 20.88
EV to Operating Cash Flow
15.78 19.17 18.70 18.22 19.63
Tangible Book Value Per Share
31.59 29.36 28.81 33.18 34.07
Shareholders’ Equity Per Share
31.22 28.90 28.37 32.97 33.83
Tax and Other Ratios
Effective Tax Rate
>-0.01 0.00 0.65 0.44 0.27
Revenue Per Share
7.51 7.37 6.21 6.53 7.45
Net Income Per Share
3.10 3.13 0.52 1.36 3.03
Tax Burden
1.01 1.01 0.35 0.56 0.73
Interest Burden
0.94 0.71 0.61 0.70 0.79
Research & Development to Revenue
0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
0.07 0.06 0.09 0.06 0.04
Stock-Based Compensation to Revenue
0.01 0.01 0.03 0.03 <0.01
Income Quality
1.55 1.37 2.83 1.88 1.25
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis